Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alnylam Pharmaceuticals

323.54
-1.4600-0.45%
Volume:245.81K
Turnover:79.35M
Market Cap:42.19B
PE:-154.19
High:324.32
Open:323.51
Low:321.01
Close:325.00
Loading ...

Alnylam Pharmaceuticals Is Maintained at Outperform by BMO Capital

Dow Jones
·
Yesterday

Alnylam Pharmaceuticals Promotes Pushkal Garg to Chief R&D Officer to Lead Integrated Innovation Efforts

Reuters
·
18 Jun

Alnylam Announces Promotion of Pushkal Garg to Chief Research and Development Officer

THOMSON REUTERS
·
18 Jun

RBC Capital Remains a Buy on Alnylam Pharma (ALNY)

TIPRANKS
·
13 Jun

Alnylam Pharmaceuticals Is Maintained at Overweight by JP Morgan

Dow Jones
·
12 Jun

European Commission Approves Alnylam's AMVUTTRA® for Treatment of ATTR Amyloidosis with Cardiomyopathy

Reuters
·
09 Jun

Alnylam Receives European Commission Approval for Amvuttra® (Vutrisiran) for the Treatment of Attr Amyloidosis With Cardiomyopathy

THOMSON REUTERS
·
09 Jun

US appeals court sides with Moderna on COVID patent claims

Reuters
·
04 Jun

RBC Capital Sticks to Its Buy Rating for Alnylam Pharma (ALNY)

TIPRANKS
·
30 May

TransCode Therapeutics Appoints Dr. Phillip D. Zamore to Scientific Advisory Board to Drive RNA Oncology Advancements

Reuters
·
28 May

Alnylam Pharmaceuticals to Present at Goldman Sachs 46th Annual Global Healthcare Conference

Reuters
·
28 May

Alnylam Pharma (ALNY) Receives a Buy from Barclays

TIPRANKS
·
27 May

Alnylam Pharmaceuticals Releases 2024 ESG Report Highlighting Environmental Impact and Health Equity Initiatives

Reuters
·
20 May

TD Cowen Reaffirms Their Buy Rating on Alnylam Pharma (ALNY)

TIPRANKS
·
19 May

U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, UnitedHealth, Wells Fargo

Reuters
·
15 May

Arbutus Biopharma Q1 2025: Revenue Up 20% to $1.8M, Net Loss Widens to $24.5M, EPS at $(0.13)

Reuters
·
14 May

Alnylam Pharmaceuticals Inc. Conducted Annual Meeting of Stockholders

Reuters
·
14 May

Evercore ISI Keeps Their Buy Rating on Alnylam Pharma (ALNY)

TIPRANKS
·
07 May

Alnylam to Webcast Presentation at BofA Securities 2025 Health Care Conference

Business Wire
·
05 May

Analyst Estimates: Here's What Brokers Think Of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) After Its First-Quarter Report

Simply Wall St.
·
04 May